Spectinomycin

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Spectinomycin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1971. DrugCentral lists 1 molecular target, including rpsL. Recorded indications include Acute gonococcal cervicitis, Acute gonococcal urethritis, Disseminated Gonococcal Infection and Gonorrhea.

• Approval status: ofm (first approved 1971 by the FDA).
• Molecular targets: rpsL (1 listed in DrugCentral).
• Indications: Acute gonococcal cervicitis, Acute gonococcal urethritis, Disseminated Gonococcal Infection, Gonorrhea and Gonorrhea of rectum.
• ATC code: J01XX04 (Other antibacterials).
• Molecular formula: C14H24N2O7; molecular weight 332.35 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (5)

• Acute gonococcal cervicitis
• Acute gonococcal urethritis
• Disseminated Gonococcal Infection
• Gonorrhea
• Gonorrhea of rectum

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
30S ribosomal protein S12	rpsL	unknown	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1971-06-30	FDA	—	PFIZER

ATC classification

ATC code	Therapeutic hierarchy
J01XX04	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER ANTIBACTERIALS › Other antibacterials

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Spectinomycin is on its molecule page.

• Molecular formula: C₁₄H₂₄N₂O₇
• Molecular weight: 332.35 g/mol
• CAS number: —
• InChIKey: UNFWWIHTNXNPBV-WXKVUWSESA-N
• PubChem CID: 15541

CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Spectinomycin used for?

DrugCentral lists the following indications for Spectinomycin: Acute gonococcal cervicitis, Acute gonococcal urethritis, Disseminated Gonococcal Infection, Gonorrhea and Gonorrhea of rectum.

How does Spectinomycin work?

Its molecular targets in DrugCentral include rpsL.

When was Spectinomycin first approved?

Spectinomycin was first approved by the FDA in 1971.

What is the chemical formula of Spectinomycin?

Spectinomycin has the molecular formula C14H24N2O7 and a molecular weight of 332.35 g/mol.

Sources

• DrugCentral drug card 2468 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1167 — compound record and bioactivity
• PubChem CID 15541 — chemical identifiers
• DrugBank DB00919 — drug record
• FDA UNII 93AKI1U6QF — substance identity
• DailyMed: FDA labels for Spectinomycin — current prescribing information (label search)

How this page is built: methodology · editorial policy & corrections.